Financial Sense Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Financial Sense Advisors, Inc.

  • $323 Million
  • Q3 2024

A detailed history of Financial Sense Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 248,500 shares of TEVA stock, worth $4.25 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
248,500
Previous 244,500 1.64%
Holding current value
$4.25 Million
Previous $3.97 Million 12.69%
% of portfolio
1.38%
Previous 1.37%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$15.81 - $18.96 $63,240 - $75,840
4,000 Added 1.64%
248,500 $4.48 Million
Q2 2024

Jul 23, 2024
SELL
$12.78 - $17.4 $291,511 - $396,893
-22,810 Reduced 8.53%
244,500 $3.97 Million
Q1 2024

Apr 19, 2024
BUY
$10.67 - $14.43 $184,697 - $249,783
17,310 Added 6.92%
267,310 $3.77 Million
Q4 2023

Jan 12, 2024
BUY
$8.12 - $10.63 $11,367 - $14,882
1,400 Added 0.56%
250,000 $2.61 Million
Q2 2023

Aug 02, 2023
SELL
$7.2 - $9.47 $25,200 - $33,145
-3,500 Reduced 1.39%
248,600 $1.87 Million
Q1 2023

Apr 24, 2023
SELL
$8.36 - $11.37 $33,440 - $45,480
-4,000 Reduced 1.56%
252,100 $2.23 Million
Q4 2022

Feb 06, 2023
SELL
$7.95 - $9.48 $399,090 - $475,896
-50,200 Reduced 16.39%
256,100 $2.34 Million
Q3 2022

Oct 13, 2022
BUY
$6.86 - $11.95 $336,140 - $585,550
49,000 Added 19.04%
306,300 $2.47 Million
Q2 2022

Jul 18, 2022
BUY
$7.38 - $10.4 $1.9 Million - $2.68 Million
257,300 New
257,300 $1.94 Million
Q1 2022

May 05, 2022
SELL
$7.33 - $9.39 $1.52 Million - $1.95 Million
-207,500 Closed
0 $0
Q4 2021

Jan 31, 2022
SELL
$7.9 - $10.19 $408,430 - $526,823
-51,700 Reduced 19.95%
207,500 $1.66 Million
Q3 2021

Nov 03, 2021
SELL
$8.38 - $10.18 $16,466 - $20,003
-1,965 Reduced 0.75%
259,200 $2.53 Million
Q2 2021

Jul 29, 2021
BUY
$9.9 - $11.56 $510,493 - $596,091
51,565 Added 24.6%
261,165 $2.59 Million
Q1 2021

Apr 28, 2021
BUY
$10.34 - $12.81 $113,740 - $140,910
11,000 Added 5.54%
209,600 $2.42 Million
Q4 2020

Feb 03, 2021
SELL
$8.61 - $11.04 $27,552 - $35,328
-3,200 Reduced 1.59%
198,600 $1.92 Million
Q3 2020

Oct 21, 2020
SELL
$8.57 - $12.69 $419,441 - $621,086
-48,943 Reduced 19.52%
201,800 $1.82 Million
Q2 2020

Jul 20, 2020
SELL
$8.12 - $13.12 $28,476 - $46,011
-3,507 Reduced 1.38%
250,743 $3.09 Million
Q1 2020

Apr 20, 2020
BUY
$6.69 - $13.45 $330,820 - $665,102
49,450 Added 24.15%
254,250 $2.28 Million
Q4 2019

Jan 23, 2020
BUY
$6.53 - $10.72 $449,264 - $737,536
68,800 Added 50.59%
204,800 $2.01 Million
Q3 2019

Nov 08, 2019
SELL
$6.16 - $9.6 $52,360 - $81,600
-8,500 Reduced 5.88%
136,000 $936,000
Q2 2019

Aug 02, 2019
SELL
$8.12 - $15.72 $32,886 - $63,666
-4,050 Reduced 2.73%
144,500 $1.33 Million
Q1 2019

May 06, 2019
BUY
$15.58 - $20.01 $592,819 - $761,380
38,050 Added 34.43%
148,550 $2.33 Million
Q4 2018

Feb 07, 2019
BUY
$14.59 - $23.84 $120,732 - $197,276
8,275 Added 8.09%
110,500 $1.7 Million
Q3 2018

Nov 01, 2018
BUY
$21.06 - $25.65 $110,565 - $134,662
5,250 Added 5.41%
102,225 $2.2 Million
Q2 2018

Jul 26, 2018
BUY
$16.77 - $24.71 $406,420 - $598,846
24,235 Added 33.32%
96,975 $2.36 Million
Q1 2018

Apr 30, 2018
BUY
$16.68 - $22.07 $531,091 - $702,708
31,840 Added 77.85%
72,740 $1.24 Million
Q4 2017

Feb 09, 2018
BUY
$11.23 - $19.1 $459,307 - $781,190
40,900
40,900 $775,000

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Financial Sense Advisors, Inc. Portfolio

Follow Financial Sense Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email